This seminar database is provided by HPMI as a library of resources intended for personal use only. To obtain recognition of educational activity for continuing professional development (CPD), you can become a HPMI member which will allow you to attend events.
Membership information can be found here.
< Go back
| -Modern Cancer Immunotherapy - PD-1/PD-l1 Blockade and Evolving Combination Therapies |
Dr Oliver Klein |
2018 |
|
Presentation |
Video |
|
|
|
